GlassScriptPhysician profile
Paul Barnette
NPI 1427700368
$2,600.91
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,251 · 2023: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $600.36 | 2022-2023 | Fasenra |
| Glaxosmithkline, LLC. | $431.93 | 2022-2023 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $261.43 | 2022-2023 | Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $253.21 | 2022-2023 | Prolastin-C Liquid |
| United Therapeutics Corporation | $146.52 | 2022-2023 | Tyvaso |
| Baxter Healthcare | $134.93 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $110.62 | 2022 | |
| Philips North America LLC | $102.97 | 2022-2023 | |
| Genzyme Corporation | $95.07 | 2022 | |
| Amgen INC. | $93.75 | 2022-2023 | Tezspire |
| Mylan Specialty L.P. | $88.19 | 2022-2023 | Yupelri |
| Inogen, INC. | $54.12 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $48.69 | 2022 | |
| Gilead Sciences, INC. | $39.82 | 2022 | |
| Csl Behring | $32.40 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $27.11 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $19.39 | 2022 | |
| Abbvie INC. | $16.97 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $15.74 | 2023 | Opsumit, Uptravi |
| Paratek Pharmaceuticals, INC. | $15.32 | 2022 | |
| Pulmonx Corporation | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Barnette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.